NCT03121248View on ClinicalTrials.gov

Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years

NAActive, not recruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2026

Conditions
Breastcancer
Interventions
RADIATION

WBI 5 fractions

External beam radiotherapy in 5 fractions of 5,7Gy

RADIATION

WBI 15 fractions

External beam radiotherapy in 15 fractions of 2,67Gy

RADIATION

LNI 5 fractions

External beam radiotherapy in 5 fractions of 5,4Gy

RADIATION

LNI 15 fractions

External beam radiotherapy in 15 fractions of 2,67Gy

RADIATION

SIB 5 fractions if needed

Simultaneous boost of 5 x 6,2Gy (6,5Gy in case of involved resection margins) if needed

RADIATION

SIB 15 fractions if needed

Simultaneous boost of 15x3,12Gy (3,33Gy in case of involved resection margins) if needed

RADIATION

TWI 5 fractions

External beam radiotherapy in 5 fractions of 5,7Gy

RADIATION

TWI 15 fractions

External beam radiotherapy in 15 fractions of 2,67Gy

Trial Locations (1)

9000

Ghent University Hospital, Dept. Radiotherapy-Oncology, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03121248 - Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years | Biotech Hunter | Biotech Hunter